aaron trial: relatlimab, nivolumab and 5-azacitidine combination in r/r aml
Published 1 year ago • 75 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
1:19:17
an insider's look: innovations in malignant hematology research
-
15:41
bladder problems - rife frequencies treatment - energy & quantum medicine with bioresonance
-
9:25
improving mds management: new targets, drug combinations, and personalized and cellular therapies
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:46
a phase ii trial of pembrolizumab for richter's transformation of cll
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:18
celestial-tncll: ongoing phase iii study of sonrotoclax zanubrutinib vs ven obi for tn cll
-
3:24
pre-induction azacitidine and venetoclax to improve the bone marrow microenvironment in aml
-
1:55
the alpine trial shows improved outcomes with zanubrutinib versus ibrutinib in r/r cll
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
1:19
what's on the horizon for the treatment of mpns?
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl